All stock lists
Klaviyo, Inc. (New York Stock Exchange:KVYO)
US · Delayed Price · Currency is USD
21.11+0.52 (+2.53%)
Insider Score
––Not scored
KVYO Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
KVYO analyst forecast
KVYO analyst consensus
Moderate Buy14 ratings
Buy 11 Hold 3 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
KVYO 12-month price target
$21.00+2.7% upsideaverage of 2 firms
$22.00High
$20.00Low
Best analysts covering KVYO
- Needham55%success rate · 11 calls
- Cantor Fitzgerald50%success rate · 4 calls
- Keybanc50%success rate · 2 calls
- Piper Sandler38%success rate · 13 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
KVYO analyst ratings
| Analyst | Firm | Rating | Price target | Upside | Action | Date |
|---|---|---|---|---|---|---|
| Goldman Sachs | Neutral | $20.00 | +10.6% | Downgraded | 2026-10-16 | |
| Stifel Nicolaus | — | $22.00 | +35.2% | — | 2026-09-10 | |
| — | Citigroup | Buy | — | — | Reiterated | 2026-08-07 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-08-06 |
| — | Benchmark | Hold | — | — | Downgraded | 2026-08-06 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2026-08-06 |
| — | Macquarie | Neutral | — | — | Reiterated | 2026-08-06 |
| — | Stifel | Buy | — | — | Reiterated | 2026-08-06 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-08-06 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-08-06 |
| — | Keybanc | Overweight | — | — | Reiterated | 2026-08-06 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-08-06 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-08-06 |
| — | BTIG | Buy | — | — | Reiterated | 2026-08-06 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-08-06 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-07-24 |
| — | Stifel | Buy | — | — | Reiterated | 2026-07-10 |
| — | Macquarie | Neutral | — | — | Reiterated | 2026-05-07 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2026-05-07 |
| — | Benchmark | Buy | — | — | Reiterated | 2026-05-06 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-05-06 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-05-06 |
| — | Stifel | Buy | — | — | Reiterated | 2026-05-06 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-05-06 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-05-06 |
| — | Keybanc | Overweight | — | — | Reiterated | 2026-05-06 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-04-28 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2026-04-15 |
| — | Macquarie | Neutral | — | — | Reiterated | 2026-02-12 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-02-11 |
| — | Stifel | Buy | — | — | Reiterated | 2026-02-11 |
| — | Jefferies | Buy | — | — | Reiterated | 2026-02-11 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-02-11 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2026-02-11 |
| — | Keybanc | Overweight | — | — | Reiterated | 2026-02-11 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2026-02-11 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-02-11 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-02-11 |
| — | Benchmark | Buy | — | — | Reiterated | 2026-02-11 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-02-11 |
| — | Needham | Buy | — | — | Reiterated | 2026-02-11 |
| — | BTIG | Buy | — | — | Reiterated | 2026-02-11 |
| — | Benchmark | Buy | — | — | Reiterated | 2026-02-09 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-02-03 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-01-15 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-01-12 |
| — | Macquarie | Neutral | — | — | Reiterated | 2025-11-11 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2025-11-07 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-11-06 |
| — | Stifel | Buy | — | — | Reiterated | 2025-11-06 |
| — | Baird | Outperform | — | — | Reiterated | 2025-11-06 |
| — | Keybanc | Overweight | — | — | Reiterated | 2025-11-06 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2025-10-29 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-09-26 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2025-09-26 |
| — | Baird | Outperform | — | — | Reiterated | 2025-09-26 |
| — | Needham | Buy | — | — | Reiterated | 2025-09-26 |
| — | Morgan Stanley | Overweight | — | — | Upgraded | 2025-09-19 |
| — | Citigroup | Buy | — | — | Upgraded | 2025-08-07 |
| — | TD Cowen | Buy | — | — | Reiterated | 2025-08-06 |
KVYO earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-10 | 0.17 | 0.19 | $334.0M | $350.2M |
| 2026-05-05 | 0.19 | 0.22 | $348.6M | $358.0M |
| 2026-08-05 | 0.19 | 0.19 | $362.1M | $370.6M |
| 2026-11-04 | 0.17 | 0.00 | $379.9M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.